"Bupropion" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A unicyclic, aminoketone antidepressant. The mechanism of its therapeutic actions is not well understood, but it does appear to block dopamine uptake. The hydrochloride is available as an aid to smoking cessation treatment.
Descriptor ID |
D016642
|
MeSH Number(s) |
D02.522.818.110
|
Concept/Terms |
Bupropion- Bupropion
- Amfebutamone
- (+-)-1-(3-Chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone
|
Below are MeSH descriptors whose meaning is more general than "Bupropion".
Below are MeSH descriptors whose meaning is more specific than "Bupropion".
This graph shows the total number of publications written about "Bupropion" by people in this website by year, and whether "Bupropion" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 1 | 0 | 1 |
2006 | 1 | 0 | 1 |
2008 | 3 | 0 | 3 |
2009 | 0 | 1 | 1 |
2013 | 1 | 1 | 2 |
2015 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bupropion" by people in Profiles.
-
Behavioral Counseling and Pharmacotherapy Interventions for Tobacco Cessation in Adults, Including Pregnant Women: A Review of Reviews for the U.S. Preventive Services Task Force. Ann Intern Med. 2015 Oct 20; 163(8):608-21.
-
Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program. JAMA Intern Med. 2013 May 13; 173(9):817-9.
-
Primary care-relevant interventions for tobacco use prevention and cessation in children and adolescents: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013 Feb 19; 158(4):253-60.
-
Dopamine genes and nicotine dependence in treatment-seeking and community smokers. Neuropsychopharmacology. 2009 Sep; 34(10):2252-64.
-
Canary in a coal mine? Interest in bupropion SR use among smokers in the COMPASS trial. Nicotine Tob Res. 2008 Dec; 10(12):1815-6.
-
Extended cognitive behavior therapy for cigarette smoking cessation. Addiction. 2008 Aug; 103(8):1381-90.
-
Predictors of 12-month outcome in smokers who received bupropion sustained-release for smoking cessation. CNS Drugs. 2008; 22(3):239-56.
-
Extended treatment with bupropion SR for cigarette smoking cessation. J Consult Clin Psychol. 2006 Apr; 74(2):286-94.
-
Abstinence rates achieved with buproprion corrected. Oncology (Williston Park). 1998 Sep; 12(9):1303.